Claribel P Taylor, MD
Gastroenterology · Fremont
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 2
Offices
2 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Washington Hospital. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Taylor’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A70013 · Current
Licensed to practise in California · since 1999 · expires 2027-05-31 · Harvard Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Washington HospitalFremont, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Washington Hospital Healthcare SystemPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.188, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.164, Oct 2024 – Sep 2025
See every measure and the patient survey for Washington Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 6 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.188 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.164 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.88) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.59 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.95 (139.54 to 246.36) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 164 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 199 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 463 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 661 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 174 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 2,550 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.35) · 6,970 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,108 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.82 (1.73 to 5.91) · 1,370 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.52 (0 to 3.17) · 589 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.75 (0.25 to 3.25) · 1,315 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.19 (5.83 to 20.56) · 600 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.91 (1.04 to 8.78) · 550 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.14) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 6,079 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 114 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.367 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 480 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 33.9 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.5 · 553 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 36.8 · 648 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 590 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.7 (3.2 to 6.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.5 to 14.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 130 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.1 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 202 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.2 to 18.5) · 78 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 974 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$29,126
Medicare paid this office $29,126 for 111 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 45 | $7,762 | $158 |
| Biopsy of large bowel using a flexible endoscope | 43 | $5,655 | $132 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 17 | $3,981 | $234 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 35 | $2,875 | $82 |
| New patient visit (60+ min) | 14 | $2,760 | $197 |
See all 7 services
| Long return visit (40+ min) | 45 | $7,762 | $158 |
| Biopsy of large bowel using a flexible endoscope | 43 | $5,655 | $132 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 17 | $3,981 | $234 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 35 | $2,875 | $82 |
| New patient visit (60+ min) | 14 | $2,760 | $197 |
| Return visit (30+ min) | 18 | $2,571 | $122 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 18 | $65 | $3 |
Procedures Medicare counted
| Colonoscopy | 12 | More than 42% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 1-10 | None |
Who their Medicare patients are
111 Original Medicare patients in 2024. Average age 75 · Women 73% · Also on Medicaid 13% · Health risk score 1.03. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 59% · Diabetes 29% · Cancer 19% · Coronary heart disease 14% · Chronic kidney disease 14% · Depression 13% · Atrial fibrillation 12%.
The office billed $240,230, Medicare allowed $36,798 and paid $29,126; for 311 services of 25 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 111 | 311 | 75 | 1.03 | $240,230 | $29,126 |
| 2023 | 98 | 225 | 73 | 1.06 | $186,149 | $25,809 |
| 2022 | 100 | 256 | 75 | 1.14 | $190,528 | $28,274 |
| 2021 | 70 | 262 | 72 | 1.03 | $78,026 | $22,938 |
| 2019 | 135 | 270 | 73 | 1.22 | $222,754 | $29,695 |
| 2018 | 185 | 476 | 72 | 1.15 | $407,674 | $45,651 |
| 2017 | 203 | 541 | 72 | 1.13 | $400,080 | $47,646 |
| 2016 | 170 | 308 | 71 | 1.12 | $283,801 | $39,710 |
| 2015 | 179 | 334 | 72 | 1.23 | $327,323 | $48,714 |
| 2014 | 144 | 278 | 71 | 1.29 | $270,495 | $37,433 |
| 2013 | 165 | 305 | 71 | 0.99 | $314,902 | $41,798 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Long return visit (40+ min) | 38 | $6,757 | $157 |
| Biopsy of large bowel using a flexible endoscope | 31 | $4,012 | $129 |
| Return visit (30+ min) | 27 | $3,383 | $109 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 12 | $2,910 | $243 |
| New patient visit (60+ min) | 12 | $2,312 | $193 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 26 | $2,292 | $85 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 21 | $91 | $4 |
2022: 9 services
| Long return visit (40+ min) | 51 | $10,775 | $154 |
| New patient visit (60+ min) | 19 | $3,593 | $189 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 15 | $3,502 | $219 |
| Biopsy of large bowel using a flexible endoscope | 29 | $2,811 | $94 |
| Return visit (30+ min) | 17 | $2,206 | $105 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 24 | $1,633 | $68 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 22 | $465 | $20 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 13 | $412 | $29 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 12 | $56 | $5 |
2021: 3 services
| Long return visit (40+ min) | 63 | $14,497 | $163 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 50 | $4,293 | $30 |
| New patient visit (60+ min) | 11 | $2,146 | $195 |
2019: 7 services
| Long return visit (40+ min) | 47 | $6,667 | $119 |
| Biopsy of large bowel using a flexible endoscope | 38 | $5,911 | $152 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,370 | $182 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 26 | $2,293 | $88 |
| New patient visit (45+ min) | 13 | $1,997 | $154 |
| Return visit (30+ min) | 20 | $1,936 | $88 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 30 | $151 | $5 |
2018: 9 services
| Biopsy of large bowel using a flexible endoscope | 90 | $11,842 | $127 |
| Long return visit (40+ min) | 50 | $8,254 | $125 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 32 | $7,421 | $232 |
| New patient visit (45+ min) | 28 | $3,994 | $143 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 35 | $2,908 | $79 |
| Return visit (30+ min) | 23 | $2,573 | $86 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 33 | $561 | $11 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 63 | $306 | $5 |
| Injection beneath lining of large bowel using a flexible endoscope | 18 | $274 | $15 |
2017: 10 services
| Biopsy of large bowel using a flexible endoscope | 94 | $13,171 | $139 |
| Long return visit (40+ min) | 64 | $9,620 | $120 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 22 | $5,028 | $229 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 44 | $3,798 | $86 |
| Return visit (30+ min) | 35 | $3,564 | $94 |
| New patient visit (45+ min) | 22 | $3,103 | $141 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,948 | $177 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 60 | $876 | $9 |
| Injection beneath lining of large bowel using a flexible endoscope | 12 | $510 | $43 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 60 | $226 | $4 |
2016: 7 services
| Biopsy of large bowel using a flexible endoscope | 62 | $9,339 | $151 |
| Long return visit (40+ min) | 61 | $8,323 | $119 |
| New patient visit (45+ min) | 27 | $3,586 | $133 |
| Return visit (30+ min) | 26 | $2,597 | $93 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 11 | $2,529 | $230 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 29 | $2,451 | $85 |
| New patient visit (60+ min) | 12 | $2,179 | $182 |
2015: 7 services
| Biopsy of large bowel using a flexible endoscope | 73 | $13,743 | $188 |
| Long return visit (40+ min) | 55 | $8,611 | $129 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 18 | $4,973 | $276 |
| New patient visit (45+ min) | 24 | $3,666 | $153 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 34 | $3,560 | $102 |
| Return visit (30+ min) | 26 | $3,056 | $95 |
| New patient visit (60+ min) | 16 | $2,934 | $183 |
2014: 6 services
| Biopsy of large bowel using a flexible endoscope | 61 | $10,029 | $164 |
| Long return visit (40+ min) | 47 | $6,726 | $116 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 18 | $4,636 | $258 |
| New patient visit (45+ min) | 21 | $3,058 | $146 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 31 | $2,666 | $86 |
| Return visit (30+ min) | 13 | $1,241 | $89 |
2013: 9 services
| Biopsy of large bowel using a flexible endoscope | 66 | $10,725 | $160 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 21 | $5,156 | $234 |
| Long return visit (40+ min) | 33 | $4,952 | $127 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 35 | $4,116 | $118 |
| New patient visit (45+ min) | 29 | $3,878 | $134 |
| New patient visit (60+ min) | 13 | $2,320 | $178 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 11 | $2,080 | $189 |
| Return visit (30+ min) | 20 | $1,847 | $84 |
| Short return visit (20+ min) | 11 | $699 | $64 |
Drugs they prescribed that Part D paid
$55,762
Pharmacies billed $55,762 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 397) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
325 generic and 72 brand-name prescriptions · $55,762 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Creon | 16 | $5,423 | $339 |
| Mesalamine | 19 | $4,049 | $213 |
| Sod Sulf-Potass Sulf-Mag Sulf | 44 | $2,875 | $65 |
| Omeprazole | 79 | $1,298 | $16 |
| Colestipol | 16 | $959 | $60 |
See all 8 drugs
| Creon | 16 | $5,423 | $339 |
| Mesalamine | 19 | $4,049 | $213 |
| Sod Sulf-Potass Sulf-Mag Sulf | 44 | $2,875 | $65 |
| Omeprazole | 79 | $1,298 | $16 |
| Colestipol | 16 | $959 | $60 |
| Entecavir | 14 | $615 | $44 |
| Famotidine | 39 | $267 | $7 |
| Pantoprazole | 24 | $223 | $9 |
Year by year
| 2024 | 397 | 117 | 0% (0) | 18% | $55,762 |
| 2023 | 425 | 114 | 0% (0) | 25% | $320,214 |
| 2022 | 398 | 96 | None | 26% | $275,620 |
| 2021 | 309 | 67 | None | 18% | $77,565 |
| 2020 | 214 | 48 | 0% (0) | 20% | $46,628 |
| 2019 | 419 | 125 | 0% (0) | 30% | $126,537 |
| 2018 | 521 | 157 | None | 27% | $101,523 |
| 2017 | 428 | 147 | 0% (0) | 33% | $75,604 |
| 2016 | 314 | 116 | 0% (0) | 43% | $88,082 |
| 2015 | 363 | 118 | 0% (0) | 36% | $313,205 |
| 2014 | 296 | 95 | 0% (0) | 40% | $50,759 |
| 2013 | 341 | 129 | 0% (0) | 42% | $47,487 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Creon | 51 | $83,329 | $1,634 |
| Mesalamine | 11 | $5,510 | $501 |
| Entecavir | 12 | $4,888 | $407 |
| Sod Sulf-Potass Sulf-Mag Sulf | 30 | $2,257 | $75 |
| Omeprazole | 71 | $1,275 | $18 |
| Ondansetron | 17 | $506 | $30 |
| Pantoprazole | 25 | $400 | $16 |
| Famotidine | 38 | $352 | $9 |
| Spironolactone | 12 | $334 | $28 |
2022: 9 drugs
| Creon | 34 | $43,447 | $1,278 |
| Suprep | 23 | $2,587 | $112 |
| Omeprazole | 84 | $1,482 | $18 |
| Pantoprazole | 31 | $759 | $24 |
| Famotidine | 38 | $409 | $11 |
| Ondansetron | 11 | $367 | $33 |
| Spironolactone | 11 | $241 | $22 |
| Propranolol | 13 | $175 | $13 |
| Nortriptyline | 11 | $79 | $7 |
2021: 7 drugs
| Pantoprazole | 44 | $871 | $20 |
| Omeprazole | 56 | $823 | $15 |
| Ondansetron | 11 | $799 | $73 |
| Famotidine | 37 | $627 | $17 |
| Colestipol | 11 | $569 | $52 |
| Spironolactone | 12 | $218 | $18 |
| Furosemide | 11 | $95 | $9 |
2020: 4 drugs
| Omeprazole | 56 | $1,000 | $18 |
| Colestipol | 15 | $637 | $42 |
| Pantoprazole | 39 | $634 | $16 |
| Famotidine | 15 | $293 | $20 |
2019: 8 drugs
| Creon | 29 | $19,639 | $677 |
| Suprep | 46 | $4,608 | $100 |
| Omeprazole | 87 | $1,714 | $20 |
| Tenofovir Disoproxil | 13 | $701 | $54 |
| Pantoprazole | 47 | $697 | $15 |
| Ranitidine | 46 | $656 | $14 |
| Colestipol | 13 | $600 | $46 |
| Famotidine | 19 | $502 | $26 |
2018: 9 drugs
| Xifaxan | 12 | $25,928 | $2,161 |
| Viread | 17 | $18,203 | $1,071 |
| Lialda | 11 | $12,307 | $1,119 |
| Suprep | 69 | $6,413 | $93 |
| Creon | 12 | $6,313 | $526 |
| Entecavir | 12 | $3,412 | $284 |
| Omeprazole | 116 | $1,717 | $15 |
| Ranitidine | 70 | $766 | $11 |
| Pantoprazole | 60 | $556 | $9 |
2017: 8 drugs
| Viread | 14 | $18,329 | $1,309 |
| Adefovir Dipivoxil | 12 | $9,921 | $827 |
| Suprep | 53 | $4,655 | $88 |
| Moviprep | 26 | $2,411 | $93 |
| Colestipol | 13 | $1,427 | $110 |
| Omeprazole | 92 | $1,366 | $15 |
| Pantoprazole | 60 | $690 | $12 |
| Ranitidine | 24 | $186 | $8 |
2016: 8 drugs
| Viread | 24 | $25,923 | $1,080 |
| Amitiza | 12 | $4,497 | $375 |
| Moviprep | 28 | $2,461 | $88 |
| Suprep | 17 | $1,381 | $81 |
| Omeprazole | 69 | $818 | $12 |
| Pantoprazole | 36 | $338 | $9 |
| Peg 3350-Electrolyte | 12 | $189 | $16 |
| Ranitidine | 17 | $134 | $8 |
2015: 8 drugs
| Viread | 12 | $11,233 | $936 |
| Moviprep | 52 | $4,196 | $81 |
| Amitiza | 12 | $3,675 | $306 |
| Dexilant | 11 | $2,324 | $211 |
| Omeprazole | 94 | $1,256 | $13 |
| Lansoprazole | 13 | $636 | $49 |
| Pantoprazole | 33 | $464 | $14 |
| Ranitidine | 30 | $225 | $7 |
2014: 9 drugs
| Asacol Hd | 12 | $5,392 | $449 |
| Dexilant | 21 | $3,816 | $182 |
| Amitiza | 11 | $3,300 | $300 |
| Moviprep | 38 | $2,964 | $78 |
| Omeprazole | 69 | $1,134 | $16 |
| Pantoprazole | 47 | $654 | $14 |
| Lansoprazole | 23 | $638 | $28 |
| Prednisone | 13 | $254 | $20 |
| Ranitidine | 13 | $100 | $8 |
2013: 7 drugs
| Moviprep | 64 | $4,569 | $71 |
| Nexium | 12 | $4,206 | $351 |
| Amitiza | 11 | $2,932 | $267 |
| Dexilant | 12 | $1,857 | $155 |
| Omeprazole | 87 | $1,849 | $21 |
| Pantoprazole | 23 | $488 | $21 |
| Ranitidine | 30 | $286 | $10 |
Money from drug and device companies
$105 in 2025
| 2025 | 1 | 1 | None | $105 |
| 2024 | 1 | 1 | None | $101 |
| 2019 | 7 | 12 | None | $221 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Biotech | Tremfya | $105 | 1 payment
|
See the published payment
| Janssen Biotech | Meals · 2025-02-06 | Tremfya | $105 |
See earlier years (2024, 2019)
2024: $101
| Lilly USA | Omvoh | $101 | 1 payment
|
2019: $221
| AbbVie | Mavyret | $65 | 3 payments
|
| Janssen Biotech | Stelara | $51 | 3 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $41 | 2 payments
|
| Ferring Pharmaceuticals | Clenpiq | $22 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Xerese | $18 | 1 payment
|
| Gilead Sciences | None | $13 | 1 payment
|
| Allergan | Viberzi | $12 | 1 payment
|
Professional record
- NPI
- 1649230418
- Licence
- CA A70013California A70013: Current · expires 2027-05-31
- Trained
- Harvard Medical School, 1998
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-03-24
- NPI last updated
- 2020-05-26
- NPI record certified
- 2020-05-26
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 795 El Camino Real, Palo Alto, CA, 94301